Al-Abbadi Zaid, Sagili Suresh, Malhotra Raman
Corneoplastic Unit, Queen Victoria Hospital, East Grinstead, West Sussex, UK.
Br J Ophthalmol. 2014 Dec;98(12):1686-90. doi: 10.1136/bjophthalmol-2014-305159. Epub 2014 Jul 3.
We describe a minimally invasive technique and report our experience of posterior approach levator plication ('levatorpexy') for congenital ptosis.
Retrospective review.
Consecutive series of 16 patients.
Posterior approach levatorpexy was performed for congenital ptosis under general anaesthesia. This surgical procedure involves exposing the posterior surface of the levator muscle through a transconjunctival approach. The levator muscle is advanced and plicated using a suture passed through its posterior surface, partial-thickness, to tarsal plate and tied on the skin. No tissue (conjunctiva, Muller's muscle, levator) are excised during this procedure.
Data collected included margin reflex distance (MRD1), symmetry of eyelid height, contour and complications. Surgery was considered successful if the following three criteria were simultaneously met: A postoperative MRD1 of ≥2 mm and ≤4.5 mm, inter-eyelid height asymmetry of ≤1 mm, and satisfactory eyelid contour.
Mean age was 9.1 years (range 3-26 years). Mean postoperative follow-up was 8.1 months (4-24 months). Preoperative phenylephrine test was positive in 81% of patients. Mean levator function was 11 mm (5-15 mm). Mean preoperative MRD1 was 1.5 mm and the mean postoperative MRD1 was 2.6 mm. Fourteen patients (87%) achieved the desired eyelid height and fulfilled our criteria set for success.
Posterior approach levatorpexy appears to be a safe and effective procedure for correction of congenital ptosis particularly with moderate or better levator function.
我们描述一种微创技术,并报告我们采用后入路提上睑肌折叠术(“提上睑肌固定术”)治疗先天性上睑下垂的经验。
回顾性研究。
连续纳入16例患者。
在全身麻醉下对先天性上睑下垂患者实施后入路提上睑肌固定术。该手术通过经结膜入路暴露提上睑肌的后表面。使用缝线穿过提上睑肌后表面(部分厚度)至睑板,将提上睑肌前移并折叠,然后在皮肤上打结。在此手术过程中不切除任何组织(结膜、米勒肌、提上睑肌)。
收集的数据包括边缘反射距离(MRD1)、睑裂高度对称性、外形及并发症。若同时满足以下三个标准,则认为手术成功:术后MRD1≥2 mm且≤4.5 mm、睑裂高度不对称≤1 mm、睑外形满意。
平均年龄为9.1岁(范围3 - 26岁)。术后平均随访时间为8.1个月(4 - 24个月)。81%的患者术前苯肾上腺素试验呈阳性。平均提上睑肌功能为11 mm(5 - 15 mm)。术前平均MRD1为1.5 mm,术后平均MRD1为2.6 mm。14例患者(87%)达到了理想的睑裂高度,并符合我们设定的成功标准。
后入路提上睑肌固定术似乎是一种安全有效的治疗先天性上睑下垂的方法,尤其是对于提上睑肌功能为中度或更好的患者。